Predictive oncology hires investor relations firm

Minneapolis, jan. 05, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, is pleased to announce that it has engaged landon capital to provide investor relations services effective december 30, 2020.  services will include introductions to investors, financial and industry analysts, registered brokers and financial writers with a view to informing such groups about developments in the company's business and affairs. landon capital will assist to develop a database of individuals, financial institutions or other persons potentially interested in receiving publicly available information relating to the company and making efforts to efficiently provide such information.
POAI Ratings Summary
POAI Quant Ranking